Comment on: "A Systematic Review of Sodium Zirconium Cyclosilicate for Hyperkalemia Management in Heart Failure and Chronic Kidney Disease"

Authors

DOI:

https://doi.org/10.5281/zenodo.21808555

Abstract

n/a 

References

Çankaya E, Gürlek Akol Z, Akgür S. A systematic review of sodium zirconium cyclosilicate for hyperkalemia management in heart failure and chronic kidney disease. J Eur Int Med Prof. 2026;4(1):32-40. https://doi.org/10.5281/zenodo.18461609

Desai NR, Kammerer J, Budden J, Olopoenia A, Tysseling A, Gordon A. The Association of Heart Failure and Edema Events between Patients Initiating Sodium Zirconium Cyclosilicate or Patiromer. Kidney360. 2024;5(12):1835-1843. doi:10.34067/KID.0000000586

Zhuo M, Kim SC, Patorno E, Paik JM. Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer. J Card Fail. 2022;28(9):1414-1423. doi:10.1016/j.cardfail.2022.04.003

Published

2026-08-06

How to Cite

Ergün, G. (2026). Comment on: "A Systematic Review of Sodium Zirconium Cyclosilicate for Hyperkalemia Management in Heart Failure and Chronic Kidney Disease". Journal of European Internal Medicine Professionals, 4(3), 126–127. https://doi.org/10.5281/zenodo.21808555